IR
58
-2
DTE
47
-2
TGNA
53
-3
BA
65
2
ALLE
35
-2
CFG
48
-2
DOW
36
-2
FFIV
70
3
MTCH
40
-10
CI
36
-4
AKAM
61
3
VZ
37
-2
L
58
3
EXC
51
-2
TROW
54
-2
GPC
37
-3
HCP
52
9
UNP
40
-3
URBN
70
-2
EFX
46
2
IR
58
-2
DTE
47
-2
TGNA
53
-3
BA
65
2
ALLE
35
-2
CFG
48
-2
DOW
36
-2
FFIV
70
3
MTCH
40
-10
CI
36
-4
AKAM
61
3
VZ
37
-2
L
58
3
EXC
51
-2
TROW
54
-2
GPC
37
-3
HCP
52
9
UNP
40
-3
URBN
70
-2
EFX
46
2
Financhill
Back

RBC Target 2026 Corporate BondIdxETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
76

RQO.TO
RBC Target 2026 Corporate BondIdxETF

Last Price:
18.73
Seasonality Move:
-0.83%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.82
Seasonality Move:
10.65%
Buy
76
RBC Target 2026 Corporate BondIdxETF (RQO.TO) is a Buy

Is RBC Target 2026 Corporate BondIdxETF a Buy, Sell or Hold?

  • The current RBC Target 2026 Corporate BondIdxETF [RQO.TO] share price is $18.74. The Score for RQO.TO is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • RQO.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RQO.TO Stock Price Chart

What is RBC Target 2026 Corporate BondIdxETF's stock price today?

  • The RBC Target 2026 Corporate BondIdxETF share price today is $18.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RQO.TO is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RQO.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 63.99 Buy
Chaikin Money Flow: -4843 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.64 - 18.72) Buy
Bollinger Bands (100): (18.52 - 18.7) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RQO.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.72 Buy
20-day SMA: 18.68 Buy
50-day SMA: 18.66 Buy
200-day SMA: 18.41 Buy
8-day EMA: 18.72 Buy
20-day EMA: 18.69 Buy
50-day EMA: 18.66 Buy
200-day EMA: 18.43 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

RBC Target 2026 Corporate BondIdxETF Earnings Growth & RQO.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

RBC Target 2026 Corporate BondIdxETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):